Merck Sharp & Dohme’s
MDS is a research-intensive biopharmaceutical company that develops important medicines and vaccines.
Singapore OKs molnupiravir for COVID-19 treatment
Singapore OKs molnupiravir for COVID-19 treatment
The drug is the second oral antiviral medicine authorised for COVID-19 treatment.
Most Read
1. Diffusion to confusion: Solving APAC’s healthcare coordination crisis 2. Singapore develops world-first fluorescent nanosensor to track gut health 3. AI adoption drives clinical decision support market to $10.15b 4. Medical inflation rises to 11.3% as employers face cost squeeze 5. AI moves from pilot phase to core pharma operationsResource Center
Read Here
Advertise
Sign Up
Partner Events
Event News
Fragmented care has left patients facing inconsistent advice and complex journeys.
Commentary
Beyond symptom control: Redefining IMID care in Malaysia
How decentralised clinical trials can unlock Asia's research potential
Why health system research deserves more attention